Treat-and-extend versus every-other-month regimens with aflibercept in age-related macular degeneration-Reference-Cited by-同舟云学术

Treat-and-extend versus every-other-month regimens with aflibercept in age-related macular degeneration

Published:2017-12-08 Issue:3 Volume:96 Page:e393-e398
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Haga Akira¹^ORCID,Kawaji Takahiro¹²,Ideta Ryuichi³,Inomata Yasuya¹,Tanihara Hidenobu¹

Affiliation:

1. Department of Ophthalmology; Faculty of Life Sciences; Kumamoto University; Kumamoto Japan

2. Sato Eye and Internal Medicine Clinic; Kumamoto Japan

3. Ideta Eye Hospital; Kumamoto Japan

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13607/fullpdf

Reference42 articles.

1. Anti-VEGF treatment in neovascular age-related macular degeneration: a treat-and-extend protocol over 2 years;Abedi;Retina,2014

2. The role of vascular endothelial growth factor in ocular health and disease;Adamis;Retina,2005

3. Two year outcomes of “Treat and Extend” intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration;Barthelmes;Retina,2017

4. Ranibizumab or Bevacizumab for Neovascular age-related macular degeneration according to the Lucentis compared to Avastin study treat-and-extend protocol: two-year results;Berg;Ophthalmology,2016

5. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients;Brown;Am J Ophthalmol,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linking disease activity with optical coherence tomography angiography in neovascular age related macular degeneration using artificial intelligence;Scientific Reports;2024-08-20

2. Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis;BMJ Open Ophthalmology;2024-07

3. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis;Ophthalmic Research;2024-05-21

4. The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France;Ophthalmology and Therapy;2024-04-16

5. Long Intervals between Intravitreal Injections Using a Treat-and-Extend Protocol in a Real-Life Context in AMD: The LIRE Study;Ophthalmologica;2023-12-15